Annual EBITDA:
$147.03M+$117.06M(+390.68%)Summary
- As of today, ADMA annual EBITDA is $147.03 million, with the most recent change of +$117.06 million (+390.68%) on December 31, 2024.
- During the last 3 years, ADMA annual EBITDA has risen by +$200.15 million (+376.80%).
- ADMA annual EBITDA is now at all-time high.
Performance
ADMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$53.04M+$8.18M(+18.24%)Summary
- As of today, ADMA quarterly EBITDA is $53.04 million, with the most recent change of +$8.18 million (+18.24%) on September 30, 2025.
- Over the past year, ADMA quarterly EBITDA has increased by +$11.46 million (+27.56%).
- ADMA quarterly EBITDA is now at all-time high.
Performance
ADMA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$175.01M+$11.46M(+7.01%)Summary
- As of today, ADMA TTM EBITDA is $175.01 million, with the most recent change of +$11.46 million (+7.01%) on September 30, 2025.
- Over the past year, ADMA TTM EBITDA has increased by +$51.91 million (+42.17%).
- ADMA TTM EBITDA is now at all-time high.
Performance
ADMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +390.7% | +27.6% | +42.2% |
| 3Y3 Years | +376.8% | +811.5% | +539.7% |
| 5Y5 Years | +485.2% | +515.5% | +436.7% |
ADMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +376.8% | at high | +811.5% | at high | +539.7% |
| 5Y | 5-Year | at high | +341.1% | at high | +431.7% | at high | +387.0% |
| All-Time | All-Time | at high | +341.1% | at high | +426.6% | at high | +387.0% |
ADMA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $53.04M(+18.2%) | $175.01M(+7.0%) |
| Jun 2025 | - | $44.86M(+21.7%) | $163.55M(+2.3%) |
| Mar 2025 | - | $36.85M(-8.5%) | $159.94M(+8.8%) |
| Dec 2024 | $147.03M(+390.7%) | $40.27M(-3.2%) | $147.03M(+19.4%) |
| Sep 2024 | - | $41.58M(+0.8%) | $123.10M(+33.4%) |
| Jun 2024 | - | $41.25M(+72.3%) | $92.30M(+75.2%) |
| Mar 2024 | - | $23.93M(+46.5%) | $52.68M(+75.8%) |
| Dec 2023 | $29.96M(+192.3%) | $16.34M(+51.6%) | $29.96M(+215.4%) |
| Sep 2023 | - | $10.78M(+563.4%) | $9.50M(+208.8%) |
| Jun 2023 | - | $1.62M(+33.2%) | -$8.73M(+51.0%) |
| Mar 2023 | - | $1.22M(+129.6%) | -$17.81M(+44.8%) |
| Dec 2022 | -$32.46M(+38.9%) | -$4.12M(+44.7%) | -$32.25M(+19.0%) |
| Sep 2022 | - | -$7.45M(-0.1%) | -$39.80M(+12.3%) |
| Jun 2022 | - | -$7.45M(+43.7%) | -$45.36M(+13.0%) |
| Mar 2022 | - | -$13.22M(-13.3%) | -$52.17M(+1.3%) |
| Dec 2021 | -$53.12M(+12.9%) | -$11.67M(+10.3%) | -$52.88M(+7.5%) |
| Sep 2021 | - | -$13.01M(+8.7%) | -$57.19M(-0.4%) |
| Jun 2021 | - | -$14.26M(-2.3%) | -$56.94M(+3.4%) |
| Mar 2021 | - | -$13.93M(+12.8%) | -$58.93M(+3.4%) |
| Dec 2020 | -$60.97M(-59.8%) | -$15.99M(-25.2%) | -$60.97M(-17.3%) |
| Sep 2020 | - | -$12.77M(+21.4%) | -$51.98M(-9.6%) |
| Jun 2020 | - | -$16.24M(-1.6%) | -$47.45M(-13.7%) |
| Mar 2020 | - | -$15.98M(-128.4%) | -$41.74M(-9.4%) |
| Dec 2019 | -$38.17M(+27.9%) | -$7.00M(+15.0%) | -$38.17M(+18.4%) |
| Sep 2019 | - | -$8.23M(+21.8%) | -$46.79M(+9.1%) |
| Jun 2019 | - | -$10.53M(+15.1%) | -$51.50M(+3.8%) |
| Mar 2019 | - | -$12.40M(+20.6%) | -$53.54M(+5.8%) |
| Dec 2018 | -$52.94M(-67.7%) | -$15.62M(-20.7%) | -$56.84M(-25.6%) |
| Sep 2018 | - | -$12.94M(-3.0%) | -$45.26M(+1.4%) |
| Jun 2018 | - | -$12.57M(+19.9%) | -$45.90M(-10.7%) |
| Mar 2018 | - | -$15.70M(-289.0%) | -$41.46M(-31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$31.57M(-87.3%) | -$4.04M(+70.3%) | -$31.57M(-0.7%) |
| Sep 2017 | - | -$13.59M(-67.3%) | -$31.36M(-46.6%) |
| Jun 2017 | - | -$8.12M(-39.6%) | -$21.39M(-14.8%) |
| Mar 2017 | - | -$5.82M(-52.1%) | -$18.64M(-10.5%) |
| Dec 2016 | -$16.86M(-12.1%) | -$3.83M(-5.7%) | -$16.86M(+1.1%) |
| Sep 2016 | - | -$3.62M(+32.7%) | -$17.05M(+5.2%) |
| Jun 2016 | - | -$5.37M(-33.0%) | -$17.97M(-12.3%) |
| Mar 2016 | - | -$4.04M(-0.7%) | -$16.00M(-6.3%) |
| Dec 2015 | -$15.04M(+4.6%) | -$4.01M(+11.7%) | -$15.04M(-2.7%) |
| Sep 2015 | - | -$4.55M(-33.8%) | -$14.64M(-11.9%) |
| Jun 2015 | - | -$3.40M(-10.2%) | -$13.08M(+1.1%) |
| Mar 2015 | - | -$3.09M(+14.6%) | -$13.22M(+16.2%) |
| Dec 2014 | -$15.77M(-6.3%) | -$3.61M(-21.0%) | -$15.77M(+5.1%) |
| Sep 2014 | - | -$2.98M(+15.7%) | -$16.63M(-3.5%) |
| Jun 2014 | - | -$3.54M(+37.2%) | -$16.06M(+5.6%) |
| Mar 2014 | - | -$5.64M(-26.2%) | -$17.01M(-21.3%) |
| Dec 2013 | -$14.83M(-91.9%) | -$4.47M(-84.5%) | -$14.03M(-19.3%) |
| Sep 2013 | - | -$2.42M(+46.1%) | -$11.76M(+6.2%) |
| Jun 2013 | - | -$4.49M(-69.5%) | -$12.54M(-36.1%) |
| Mar 2013 | - | -$2.65M(-20.5%) | -$9.21M(-19.2%) |
| Dec 2012 | -$7.73M(-213.0%) | -$2.20M(+31.3%) | -$7.73M(-39.8%) |
| Sep 2012 | - | -$3.20M(-175.8%) | -$5.53M(-137.4%) |
| Jun 2012 | - | -$1.16M(+0.6%) | -$2.33M(-99.4%) |
| Mar 2012 | - | -$1.17M(>-9900.0%) | -$1.17M(-5136.8%) |
| Dec 2011 | -$2.47M(+53.2%) | - | - |
| Mar 2011 | - | -$4900.00(+5.8%) | -$22.30K(-0.5%) |
| Dec 2010 | -$5.28M(>-9900.0%) | -$5200.00(-13.0%) | -$22.20K(-4.2%) |
| Sep 2010 | - | -$4600.00(+39.5%) | -$21.30K(-27.5%) |
| Jun 2010 | - | -$7600.00(-58.3%) | -$16.70K(-83.5%) |
| Jun 2010 | -$20.50K | - | - |
| Mar 2010 | - | -$4800.00(-11.6%) | -$9100.00(-111.6%) |
| Dec 2009 | - | -$4300.00 | -$4300.00 |
FAQ
- What is ADMA Biologics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual EBITDA year-on-year change?
- What is ADMA Biologics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly EBITDA year-on-year change?
- What is ADMA Biologics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM EBITDA year-on-year change?
What is ADMA Biologics, Inc. annual EBITDA?
The current annual EBITDA of ADMA is $147.03M
What is the all-time high annual EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual EBITDA is $147.03M
What is ADMA Biologics, Inc. annual EBITDA year-on-year change?
Over the past year, ADMA annual EBITDA has changed by +$117.06M (+390.68%)
What is ADMA Biologics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ADMA is $53.04M
What is the all-time high quarterly EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly EBITDA is $53.04M
What is ADMA Biologics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ADMA quarterly EBITDA has changed by +$11.46M (+27.56%)
What is ADMA Biologics, Inc. TTM EBITDA?
The current TTM EBITDA of ADMA is $175.01M
What is the all-time high TTM EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM EBITDA is $175.01M
What is ADMA Biologics, Inc. TTM EBITDA year-on-year change?
Over the past year, ADMA TTM EBITDA has changed by +$51.91M (+42.17%)